Morgan Stanley’s CalciMedica CALC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$148K Buy
+28,649
New +$102K ﹤0.01% 6090
2025
Q4
– Sell
-171
Closed -$2.63K – 8240
2025
Q3
$2.63K Hold
171
– – ﹤0.01% 7250
2025
Q2
$1.37K Hold
171
– – ﹤0.01% 7296
2025
Q1
$1.64K Hold
171
– – ﹤0.01% 7210
2024
Q4
$3.03K Hold
171
– – ﹤0.01% 7113
2024
Q3
$3.79K Hold
171
– – ﹤0.01% 6986
2024
Q2
$3.39K Hold
171
– – ﹤0.01% 6952
2024
Q1
$3.56K Hold
171
– – ﹤0.01% 6967
2023
Q4
$2.45K Sell
171
-140
-45% -$2.02K ﹤0.01% 7010
2023
Q3
$4.14K Hold
311
– – ﹤0.01% 6953
2023
Q2
$6.24K Buy
+311
New +$6.8K ﹤0.01% 6935
2023
Q1
– Sell
-192
Closed -$6.71K – 7725
2022
Q4
$6.71K Buy
192
+20
+12% +$1.12K ﹤0.01% 7072
2022
Q3
$11K Buy
172
+43
+33% +$3.04K ﹤0.01% 7035
2022
Q2
$10K Sell
129
-2,174
-94% -$148K ﹤0.01% 7200
2022
Q1
$198K Sell
2,303
-3,345
-59% -$319K ﹤0.01% 5931
2021
Q4
$724K Buy
5,648
+1,277
+29% +$248K ﹤0.01% 5306
2021
Q3
$1.02M Sell
4,371
-4,335
-50% -$1.22M ﹤0.01% 5029
2021
Q2
$3.31M Sell
8,706
-4,547
-34% -$1.49M ﹤0.01% 4192
2021
Q1
$5.15M Buy
13,253
+13,182
+18,566% +$19.7M ﹤0.01% 3379
2020
Q4
$144K Buy
+71
New +$105K ﹤0.01% 5756

Other funds holding CALC

Morgan Stanley's CALC Position: Q2 2026 in Review

Morgan Stanley opened a new position in CalciMedica (CALC) in Q2 2026: 28,649 shares worth $148K. The stake represents ﹤0.01% of the portfolio and ranks #6090 among its holdings. This is a return to the name: Morgan Stanley previously reported a position in CALC as recently as Q3 2025.

Morgan Stanley first reported a position in CALC in Q4 2020 and has held it in 20 quarters since. The position peaked at $5.15M in Q1 2021. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

  • Morgan Stanley held 28,649 shares of CalciMedica worth $148K as of Q2 2026.
  • CalciMedica was a new Morgan Stanley position in Q2 2026.
  • CalciMedica made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6090 holding.
  • Morgan Stanley first reported a position in CalciMedica in Q4 2020 and has held it in 20 quarters since.
  • Morgan Stanley's CalciMedica position peaked at $5.15M in Q1 2021.
  • 31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.